Jocelyn Solis-Moreira
Inverse
Contact Jocelyn
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Jocelyn:
The right time to make a decision may depend on this overlooked biological factor
Whether alone, at work, or at the store, making decisions (especially big ones) can be tough at the best of times. But time is that, exactly? Here's what we know about when to make big decisions depending on your scenario. → Read More
Most-effective core exercises: Why traditional sit-ups may not be best for your routine
Boosting your ab game takes work — and the first step is to let go of the idea that “abs” equates to “core.” → Read More
Even Mild COVID-19 Infections Increase Risk of Type 2 Diabetes, Research Shows
The new study is the first to look at the relationship between mild infections and diabetes. → Read More
Here's What Gender Affirming Medical Care Involves and Why It Can Be Lifesaving
Bills prohibiting and even criminalizing gender affirming medical care are popping up across the nation, but research shows that the care is critical for the health and wellbeing of transgender youth. → Read More
Black Patients Are Less Likely to Receive a Timely Dementia Diagnosis, Despite Having the Highest Risk
New research suggests Black individuals are nearly 65% less likely to receive an Alzheimer's Disease Related Dementias (ADRD) diagnosis in their first medical visit compared to White individuals. → Read More
First reported case of a cat infected with SARS-CoV-2 Delta AY.3 variant
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is hurting our loved ones — even those that walk on four legs. Researchers from the University of Pennsylvania documented the recovery of an 11-year old indoor housecat living in Delaware who first presented to the veterinary hospital after experiencing distressing gastrointestinal symptoms. → Read More
Study shows Pfizer-BioNTech booster protects over 65s against Delta and Omicron
New research in nursing home residents found that a third dose of the Pfizer-BioNTech COVID-19 vaccine was effective for at least three months in protecting against the Delta and Omicron variant. While two doses of an mRNA COVID-19 vaccine showed poor neutralization to Omicron than Delta, a booster shot increased neutralizing antibody responses. → Read More
Research identifies differences between Omicron lineages BA.1 and BA.2
Researchers recently identified another Omicron lineage, called BA.2, that is more contagious than BA.1, the Omicron lineage that sparked the winter surge of coronavirus cases in January 2022. → Read More
A New 'Highly Virulent' HIV Variant Has Been Discovered—But Treatments Are Still Effective
The VB variant is more infectious and can accelerate the progression from HIV to AIDS, according to new research. → Read More
Looking into the long-COVID brain
Neurological issues, ranging from memory lapses to trouble with attention, have been widely reported after recovery from severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection. Unfortunately, there is limited information about pathways to recovery after severe COVID hospitalization. Now, a prospective study of 4,491 patients hospitalized with COVID suggests neurological recovery… → Read More
How Biden's 'Cancer Moonshot' Initiative Plans to Halve the Cancer Death Rate in 25 Years
President Joe Biden recently announced that his administration will relaunch the federal government's Cancer Moonshot initiative with an ambitious goal: to reduce the rate of deaths from the disease by 50% over the next 25 years. Here's how the administration plans to do it. → Read More
The secret to treating Long Covid may lie in the gut microbiome
In the journal 'Gut,' a team of researchers report how gut bacteria could help predict who will develop Long Covid, and help treat the condition. → Read More
Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic
The origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has long been debated among scientists. However, prior research found early genetic material of a unique SARS-CoV-2 variant from the soil on King George Island, Antarctica between 24 December 2018 and 13th January 2019. → Read More
Scientists develop platform to track SARS-CoV-2 lineages
A team of researchers led by Laura D. Hughes from The Scripps Research Institute in California created an online platform called Outbreak.info to track over 40 million lineages and SARS-CoV-2 mutation across 7,000 locations. → Read More
COVID-19 pandemic negatively affected medical care for individuals who self-harm
In a new study, researchers found that people were less likely to seek medical help for self-harm and suicidal behavior during the COVID-19 pandemic. → Read More
Nucleocapsid antigen found to be a sensitive biomarker for acute COVID-19 infection
In a new study, researchers found that nucleocapsid antigen in the blood (antigenemia) is a sensitive and specific biomarker for acute coronavirus disease 2019 infection. → Read More
Research shows minks mimic severe COVID-19 symptoms, including ARDS
Minks may be a suitable animal model for testing severe COVID-19 infections, finds a recent bioRxiv* preprint study. While mice and ferrets are used in preclinical severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is currently no model specific to severe disease. → Read More
How to start exercising: 3 psychology-backed strategies to hit fitness goals
A sports psychologist explains three strategies to rebalance your relationship with exercise and hit your fitness goals. → Read More
Researchers discover mechanism behind SARS-CoV-2 entry into the brain
In a new study, researchers conducted an analysis of databases that have information on the transcriptomic and proteomic expression of ACE2, TMPRSS2, NRP1, and furin in several human brain areas. → Read More
Study finds stable T-Cell response against Omicron after mRNA booster vaccination
A new study measured T cell activity in vaccinated individuals and found a third vaccine provided substantial T-cell immunity against the Omicron variant of SARS-CoV-2. → Read More